Last updated: March 4, 2024
Sponsor: Advanced Bionics AG
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hearing Impairment
Auditory Loss And Deafness
Hearing Loss
Treatment
N/AClinical Study ID
NCT06301581
ABIntl-23-42
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Unilateral or bilateral HiRes Ultra CI or HiRes Ultra 3D CI users including
- Ultra Version V2 newly implanted on this side (Group 1)
- Ultra Version V2 users implanted following an Ultra Version V1 device failure inthe same ear (Group 2)
- Informed consent signed
Exclusion
Exclusion Criteria:
- no exclusion criteria
Study Design
Total Participants: 200
Study Start date:
January 22, 2024
Estimated Completion Date:
December 31, 2025
Connect with a study center
Medizinische Hochschule Hannover
Hannover, D-30625
GermanyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.